Fetuin A/Nutritional Status Predicts Cardiovascular Outcomes and Survival in Hemodialysis Patients
Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Met...
        Saved in:
      
    
          | Published in | American journal of nephrology Vol. 40; no. 3; pp. 233 - 241 | 
|---|---|
| Main Authors | , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Basel, Switzerland
          S. Karger AG
    
        01.01.2014
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0250-8095 1421-9670 1421-9670  | 
| DOI | 10.1159/000366523 | 
Cover
| Abstract | Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Methods: We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Results: Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Conclusions: Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients. | 
    
|---|---|
| AbstractList | Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Methods: We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Results: Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Conclusions: Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients. Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients. Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown. Methods: We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model. Results: Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events. Conclusions: Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients. © 2014 S. Karger AG, Basel Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown.BACKGROUNDFetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and nutritional status interact with each other to alter CV outcomes and survival in hemodialysis (HD) patients remains unknown.We performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model.METHODSWe performed a prospective study on 388 prevalent HD patients. We used the geriatric nutritional risk index (GNRI) for the evaluation of nutritional status. Study outcomes included the occurrence of CV event, CV death, and all-cause mortality during follow-up; interactions between parameters for predicting outcomes were assessed by the interaction terms in a Cox regression model.Overall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events.RESULTSOverall, 131 patients experienced CV events and 92 patients died, with 51 CV deaths. HD patients with higher fetuin A levels had lower numbers of CV events (adjusted hazard ratio [HR], 0.9; 0.81-0.99) and all-cause mortality (adjusted HR, 0.97; 0.91-0.99). However, patients with higher GNRI had lower all-cause mortality (adjusted HR, 0.79; 0.51-0.98, for every 10-unit increase). Fetuin A levels and GNRI showed a significant interaction in the prediction of CV events (adjusted HR, 1.01; 1.008-1.02) but not for all-cause or CV mortality. In patients with poor nutritional status, higher fetuin A levels were associated with fewer CV events; however, in contrast, in subjects with better nutritional status, higher fetuin A levels appeared to lead to a higher number of CV events.Fetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.CONCLUSIONSFetuin A showed a remarkable interaction with nutritional status in evaluating the risks of CV morbidities in prevalent HD patients.  | 
    
| Author | Chiu, Yen-Ling Chen, Hung-Yuan Peng, Yu-Sen Yang, Ju-Yeh Pai, Mei-Fen Hsu, Shih-Ping  | 
    
| Author_xml | – sequence: 1 givenname: Hung-Yuan surname: Chen fullname: Chen, Hung-Yuan – sequence: 2 givenname: Yen-Ling surname: Chiu fullname: Chiu, Yen-Ling – sequence: 3 givenname: Shih-Ping surname: Hsu fullname: Hsu, Shih-Ping – sequence: 4 givenname: Mei-Fen surname: Pai fullname: Pai, Mei-Fen – sequence: 5 givenname: Ju-Yeh surname: Yang fullname: Yang, Ju-Yeh – sequence: 6 givenname: Yu-Sen surname: Peng fullname: Peng, Yu-Sen email: taan70@yahoo.com.tw, ClinicalTrials.gov NCT01457625  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25322785$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNptkUtLAzEURoMo9qEL9yIDbnQx9iaZzGNZilVBVFDXQzpJJDoz0TwK_femtHZRXIS7yDkf3O-O0GFveonQGYYbjFk1AQCa54zQAzTEGcFplRdwiIZAGKQlVGyARs59AmBSQnGMBoRRQoqSDdFiLn3QfTKdPAVvtdem523y6rkPLnmxUujGu2TGrdBmyV0TWm6T5-Ab00mX8F4kr8Eu9TJKMeVedkZo3q6cjjb3WvbenaAjxVsnT7dzjN7nt2-z-_Tx-e5hNn1MG0oznyqF6WKBAbhUhClRZkB5lmcMVwyYJEIwzFQVnyJUCVLmVcYL0hC5NlVFx-hqk_ttzU-Qzteddo1sW95LE1yNc1xRApTQiF7uoZ8m2Lj5miIFxpThIlIXWyosOinqb6s7blf1X3sRuN4AjTXOWal2CIZ6fZl6d5nITvbYRseWY9_ect3-a5xvjC9uP6TdZW-_fwFr9Jc9 | 
    
| CODEN | AJNED9 | 
    
| CitedBy_id | crossref_primary_10_3389_fphys_2019_00966 crossref_primary_10_1007_s40620_019_00676_1 crossref_primary_10_3390_nu15245036 crossref_primary_10_1016_j_clnu_2016_04_010 crossref_primary_10_1177_2040622320949060  | 
    
| Cites_doi | 10.1016/S0140-6736(03)12710-9 10.1016/j.jacc.2011.08.035 10.1002/dmrr.967 10.1038/sj.ki.5002178 10.1093/ndt/gft032 10.1053/j.ajkd.2008.10.046 10.1371/journal.pone.0038415 10.1073/pnas.97.26.14478 10.2337/diacare.29.04.06.dc05-1938 10.1001/2012.jama.11132 10.1016/j.cytogfr.2006.09.002 10.1016/j.jjcc.2013.10.018 10.1016/j.jacc.2008.12.040 10.1093/ndt/gfn303 10.1111/eci.12057 10.1172/JCI17202 10.1161/CIRCULATIONAHA.105.588723 10.1111/j.1523-1755.2005.00345.x 10.1111/j.1365-2362.2008.02032.x 10.1074/jbc.M112234200 10.1159/000117817 10.1093/ndt/gfh891 10.1053/j.ajkd.2010.06.015 10.1053/j.ajkd.2005.09.014 10.1210/jc.2008-1505 10.1530/EJE-08-0813 10.4065/mcp.2010.0336  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2014 S. Karger AG, Basel 2014 S. Karger AG, Basel. Copyright (c) 2014 S. Karger AG, Basel  | 
    
| Copyright_xml | – notice: 2014 S. Karger AG, Basel – notice: 2014 S. Karger AG, Basel. – notice: Copyright (c) 2014 S. Karger AG, Basel  | 
    
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7T7 7U9 7X7 7XB 88E 88I 8AF 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 M0S M1P M2P M7N NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U S0X 7X8  | 
    
| DOI | 10.1159/000366523 | 
    
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Local Electronic Collection Information ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Science Database (ProQuest) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic SIRS Editorial MEDLINE - Academic  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE ProQuest Central Student CrossRef MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1421-9670 | 
    
| EndPage | 241 | 
    
| ExternalDocumentID | 3505605961 25322785 10_1159_000366523 366523  | 
    
| Genre | Research Support, Non-U.S. Gov't Journal Article  | 
    
| GroupedDBID | --- .55 .GJ 0R~ 0~5 0~B 23M 30W 327 34G 36B 39C 3O- 3O. 3V. 4.4 53G 5GY 5RE 6J9 7RV 7X7 88E 88I 8AF 8AO 8FI 8FJ 8UI AAWTL AAYIC ABJNI ABPAZ ABUWG ACGFO ACGFS ACGOD ACPRK ACPSR ADAGL ADBBV ADFRT AENEX AEYAO AFFNX AFJJK AFKRA AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS APPQY AZPMC AZQEC BENPR BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DWQXO E0A EBS EJD EMB EMOBN EX3 F5P FB. FYUFA GNUQQ HCIFZ HMCUK HZ~ IAO IHR IHW IY7 KUZGX M1P M2P N9A NAPCQ O1H O9- OVD P2P PQQKQ PROAC PSQYO RIG RKO RXVBD S0X SV3 TEORI UJ6 UKHRP WOW X7M ZGI ZXP AAYXX ABBTS ABWCG ACQXL AFSIO AHFRZ CITATION ITC PHGZM PHGZT PJZUB PPXIY PUEGO CGR CUY CVF ECM EIF NPM 7QL 7QP 7T7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI Q9U 7X8  | 
    
| ID | FETCH-LOGICAL-c334t-ff13bb100aef25fd8403a464519505e2dd515f915ff23fd28694a72c2eff13f93 | 
    
| IEDL.DBID | BENPR | 
    
| ISSN | 0250-8095 1421-9670  | 
    
| IngestDate | Wed Oct 01 13:51:17 EDT 2025 Mon Oct 06 16:51:03 EDT 2025 Mon Jul 21 06:06:51 EDT 2025 Thu Apr 24 23:03:33 EDT 2025 Wed Oct 01 06:31:10 EDT 2025 Thu Aug 29 12:04:49 EDT 2024  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 3 | 
    
| Keywords | Cardiovascular outcome Nutrition Fetuin A Survival Interaction  | 
    
| Language | English | 
    
| License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses 2014 S. Karger AG, Basel.  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c334t-ff13bb100aef25fd8403a464519505e2dd515f915ff23fd28694a72c2eff13f93 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
    
| PMID | 25322785 | 
    
| PQID | 1627113517 | 
    
| PQPubID | 10951 | 
    
| PageCount | 9 | 
    
| ParticipantIDs | proquest_miscellaneous_1619320323 crossref_primary_10_1159_000366523 pubmed_primary_25322785 crossref_citationtrail_10_1159_000366523 proquest_journals_1627113517 karger_primary_366523  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2014-01-01 | 
    
| PublicationDateYYYYMMDD | 2014-01-01 | 
    
| PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Basel, Switzerland | 
    
| PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel  | 
    
| PublicationTitle | American journal of nephrology | 
    
| PublicationTitleAlternate | Am J Nephrol | 
    
| PublicationYear | 2014 | 
    
| Publisher | S. Karger AG | 
    
| Publisher_xml | – name: S. Karger AG | 
    
| References | Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.1264205010.1016/S0140-6736(03)12710-9 Wang AY, Woo J, Lam CW, et al: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-1685.1589993510.1093/ndt/gfh891 Takahashi H, Ito Y, Ishii H, et al: Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients. J Cardiol 2014;64:32-36.2436538510.1016/j.jjcc.2013.10.018 Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.15755821 Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.1289720310.1172/JCI17202 Wang AY, Lam CW, Wang M, et al: Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study. Am J Nephrol 2008;28:647-653.1829265210.1159/000117817 Ix JH, Barrett-Connor E, Wassel CL, et al: The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011;58:2372-2379.2211564210.1016/j.jacc.2011.08.035 Stenvinkel P, Wang K, Qureshi AR, et al: Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.1588228310.1111/j.1523-1755.2005.00345.x Yamada K, Furuya R, Takita T, et al: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008;87:106-113.18175743 Chen HY, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS: Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis. Eur J Clin Invest 2013;43:387-396.2341913310.1111/eci.12057 Honda H, Qureshi AR, Heimburger O, et al: Serum albumin, c-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.1637739510.1053/j.ajkd.2005.09.014 Metry G, Stenvinkel P, Qureshi AR, et al: Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest 2008;38:804-811.1902169710.1111/j.1365-2362.2008.02032.x Neeland IJ, Turer AT, Ayers CR, et al: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.2299027410.1001/2012.jama.11132 Reinehr T, Roth CL: Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479-4485.1872815910.1210/jc.2008-1505 Kaushik SV, Plaisance EP, Kim T, et al: Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev 2009;25:427-434.1940504410.1002/dmrr.967 Postorino M, Marino C, Tripepi G, Zoccali C, Group CW: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009;53:1265-1272.1935893910.1016/j.jacc.2008.12.040 Kalantar-Zadeh K, Streja E, Kovesdy CP, et al: The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010;85:991-1001.2103704210.4065/mcp.2010.0336 Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13(suppl 1):S28-S36.11792759 Chen HY, Chiu YL, Chuang YF, et al: Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis 2010;56:720-727.2080156810.1053/j.ajkd.2010.06.015 Kazory A, Klein A, Chalopin JM, Ducloux D, Courivaud C: Obesity and atherosclerotic events in chronic hemodialysis patients: a prospective study. Nephrol Dial Transplant 2013;28(suppl 4):iv188-iv194.2417901210.1093/ndt/gft032 Stefan N, Hennige AM, Staiger H, et al: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857.1656782710.2337/diacare.29.04.06.dc05-1938 Chiu YL, Chen HY, Chuang YF, et al: Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008;23:3685-3689.1851565410.1093/ndt/gfn303 Chen HY, Lin CC, Chiu YL, et al: Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One 2012;7:e38415.2281569110.1371/journal.pone.0038415 Hermans MM, Brandenburg V, Ketteler M, et al: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007;72:202-207.1734217810.1038/sj.ki.5002178 Pertosa G, Simone S, Ciccone M, et al: Serum fetuin A in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis 2009;53:467-474.1916779810.1053/j.ajkd.2008.10.046 Honda H, Qureshi AR, Axelsson J, et al: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007;86:633-638.17823427 Kissebah AH, Sonnenberg GE, Myklebust J, et al: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000;97:14478-14483.1112105010.1073/pnas.97.26.14478 Chen HY, Chiu YL, Hsu SP, et al: Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777-783.1922882310.1530/EJE-08-0813 Singh NN, Ramji DP: The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev 2006;17:487-499.1705629510.1016/j.cytogfr.2006.09.002 Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA: Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 2006;113:1760-1767.1656756810.1161/CIRCULATIONAHA.105.588723 Szweras M, Liu D, Partridge EA, et al: Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002;277:19991-19997.1190115510.1074/jbc.M112234200 ref13 ref12 ref15 ref14 ref11 ref10 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref27 ref8 ref7 ref9 ref4 ref3 ref6 ref5  | 
    
| References_xml | – reference: Yamada K, Furuya R, Takita T, et al: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008;87:106-113.18175743 – reference: Neeland IJ, Turer AT, Ayers CR, et al: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.2299027410.1001/2012.jama.11132 – reference: Wang AY, Woo J, Lam CW, et al: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-1685.1589993510.1093/ndt/gfh891 – reference: Honda H, Qureshi AR, Heimburger O, et al: Serum albumin, c-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.1637739510.1053/j.ajkd.2005.09.014 – reference: Szweras M, Liu D, Partridge EA, et al: Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002;277:19991-19997.1190115510.1074/jbc.M112234200 – reference: Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-833.1264205010.1016/S0140-6736(03)12710-9 – reference: Chen HY, Chiu YL, Chuang YF, et al: Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis 2010;56:720-727.2080156810.1053/j.ajkd.2010.06.015 – reference: Postorino M, Marino C, Tripepi G, Zoccali C, Group CW: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009;53:1265-1272.1935893910.1016/j.jacc.2008.12.040 – reference: Kaushik SV, Plaisance EP, Kim T, et al: Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. Diabetes Metab Res Rev 2009;25:427-434.1940504410.1002/dmrr.967 – reference: Chiu YL, Chen HY, Chuang YF, et al: Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008;23:3685-3689.1851565410.1093/ndt/gfn303 – reference: Chen HY, Lin CC, Chiu YL, et al: Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PLoS One 2012;7:e38415.2281569110.1371/journal.pone.0038415 – reference: Metry G, Stenvinkel P, Qureshi AR, et al: Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest 2008;38:804-811.1902169710.1111/j.1365-2362.2008.02032.x – reference: Chen HY, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS: Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis. Eur J Clin Invest 2013;43:387-396.2341913310.1111/eci.12057 – reference: Hermans MM, Brandenburg V, Ketteler M, et al: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007;72:202-207.1734217810.1038/sj.ki.5002178 – reference: Singh NN, Ramji DP: The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev 2006;17:487-499.1705629510.1016/j.cytogfr.2006.09.002 – reference: Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.15755821 – reference: Kazory A, Klein A, Chalopin JM, Ducloux D, Courivaud C: Obesity and atherosclerotic events in chronic hemodialysis patients: a prospective study. Nephrol Dial Transplant 2013;28(suppl 4):iv188-iv194.2417901210.1093/ndt/gft032 – reference: Reinehr T, Roth CL: Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479-4485.1872815910.1210/jc.2008-1505 – reference: Chen HY, Chiu YL, Hsu SP, et al: Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777-783.1922882310.1530/EJE-08-0813 – reference: Pertosa G, Simone S, Ciccone M, et al: Serum fetuin A in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis 2009;53:467-474.1916779810.1053/j.ajkd.2008.10.046 – reference: Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-366.1289720310.1172/JCI17202 – reference: Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA: Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 2006;113:1760-1767.1656756810.1161/CIRCULATIONAHA.105.588723 – reference: Wang AY, Lam CW, Wang M, et al: Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study. Am J Nephrol 2008;28:647-653.1829265210.1159/000117817 – reference: Honda H, Qureshi AR, Axelsson J, et al: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007;86:633-638.17823427 – reference: Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002;13(suppl 1):S28-S36.11792759 – reference: Stefan N, Hennige AM, Staiger H, et al: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857.1656782710.2337/diacare.29.04.06.dc05-1938 – reference: Kalantar-Zadeh K, Streja E, Kovesdy CP, et al: The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010;85:991-1001.2103704210.4065/mcp.2010.0336 – reference: Kissebah AH, Sonnenberg GE, Myklebust J, et al: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000;97:14478-14483.1112105010.1073/pnas.97.26.14478 – reference: Ix JH, Barrett-Connor E, Wassel CL, et al: The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011;58:2372-2379.2211564210.1016/j.jacc.2011.08.035 – reference: Takahashi H, Ito Y, Ishii H, et al: Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients. J Cardiol 2014;64:32-36.2436538510.1016/j.jjcc.2013.10.018 – reference: Stenvinkel P, Wang K, Qureshi AR, et al: Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383-2392.1588228310.1111/j.1523-1755.2005.00345.x – ident: ref3 doi: 10.1016/S0140-6736(03)12710-9 – ident: ref14 doi: 10.1016/j.jacc.2011.08.035 – ident: ref19 doi: 10.1002/dmrr.967 – ident: ref2 doi: 10.1038/sj.ki.5002178 – ident: ref25 doi: 10.1093/ndt/gft032 – ident: ref15 doi: 10.1053/j.ajkd.2008.10.046 – ident: ref8 doi: 10.1371/journal.pone.0038415 – ident: ref22 doi: 10.1073/pnas.97.26.14478 – ident: ref17 doi: 10.2337/diacare.29.04.06.dc05-1938 – ident: ref24 doi: 10.1001/2012.jama.11132 – ident: ref12 doi: 10.1016/j.cytogfr.2006.09.002 – ident: ref27 doi: 10.1016/j.jjcc.2013.10.018 – ident: ref26 doi: 10.1016/j.jacc.2008.12.040 – ident: ref21 doi: 10.1093/ndt/gfn303 – ident: ref6 doi: 10.1111/eci.12057 – ident: ref1 doi: 10.1172/JCI17202 – ident: ref18 doi: 10.1161/CIRCULATIONAHA.105.588723 – ident: ref4 doi: 10.1111/j.1523-1755.2005.00345.x – ident: ref20 doi: 10.1111/j.1365-2362.2008.02032.x – ident: ref13 doi: 10.1074/jbc.M112234200 – ident: ref10 doi: 10.1159/000117817 – ident: ref11 doi: 10.1093/ndt/gfh891 – ident: ref5 doi: 10.1053/j.ajkd.2010.06.015 – ident: ref9 doi: 10.1053/j.ajkd.2005.09.014 – ident: ref16 doi: 10.1210/jc.2008-1505 – ident: ref7 doi: 10.1530/EJE-08-0813 – ident: ref23 doi: 10.4065/mcp.2010.0336  | 
    
| SSID | ssj0012807 | 
    
| Score | 2.0686338 | 
    
| Snippet | Background: Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether... Fetuin A - a predictor of cardiovascular (CV) outcomes in dialysis patients - is correlated with over-nutrition in the general population. Whether fetuin A and...  | 
    
| SourceID | proquest pubmed crossref karger  | 
    
| SourceType | Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 233 | 
    
| SubjectTerms | Aged alpha-2-HS-Glycoprotein - chemistry Body Weight Cardiovascular Diseases - mortality Cardiovascular Diseases - physiopathology Female Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - mortality Kidney Failure, Chronic - therapy Male Middle Aged Nutritional Status Original Report: Patient-Oriented, Translational Research Prevalence Proportional Hazards Models Prospective Studies Regression Analysis Renal Dialysis - mortality Treatment Outcome  | 
    
| Title | Fetuin A/Nutritional Status Predicts Cardiovascular Outcomes and Survival in Hemodialysis Patients | 
    
| URI | https://karger.com/doi/10.1159/000366523 https://www.ncbi.nlm.nih.gov/pubmed/25322785 https://www.proquest.com/docview/1627113517 https://www.proquest.com/docview/1619320323  | 
    
| Volume | 40 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1421-9670 dateEnd: 20151130 omitProxy: true ssIdentifier: ssj0012807 issn: 0250-8095 databaseCode: 7X7 dateStart: 19960101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1421-9670 dateEnd: 20151130 omitProxy: true ssIdentifier: ssj0012807 issn: 0250-8095 databaseCode: BENPR dateStart: 19960101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB61W4S4IB4FFkplEAcu0SZ-xM0BoVJ1tULqsgIq7S2yY1tCQLZskv_PTOIEVQIOySGZzMFjz3zxeL4BeBNSq6wJLhGVNolUWiZFqNIkVFbkRsgqDZTRvVrnq2v5cau2B7Aea2HoWOXoE3tH7XYV7ZEvspzrjNrJ6fc3vxLqGkXZ1bGFhomtFdy7nmLsEI44MWPN4OjD5Xrzecor8FhAjYEffXOhItcQxvRFT82SKy5uRag73-lA9v7f-LOPQ8sHcD8CSHY-WPwhHPj6Edy9iinyx2CXvu2-1ex8sR6J9lGcMGXXsM2e5NqGXdw6hso-dS2Ogm-YqR370qH7wAnIUMvK_9xRaQnxlrDNwMHaHMP18vLrxSqJjRSSSgjZJiFkwtosTY0PXAWHP3XCUEqTesAqz51DVBMKvAIXwfGzvJBG84p7-jIU4gnM6l3tnwFDFTLTZ9JYk0mF0d4hZtB4D9Jn1vk5vB0Hr6wiyzg1u_hR9n8bqiincZ7D60n0ZqDW-JvQ8WCBSWR8fjIapIyrrin_zJE5vJpe43qhJIip_a4jGYKsqSAVTwdDTqq5ElQZrJ7_X_kLuIewSQ4bMScwa_edf4nQpLWncKi3-jTOut9agOII | 
    
| linkProvider | ProQuest | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9RAEN4QIOqLEUU9RV2IJr401-6Plj4Qg8DlEO68KCS8ld3ubmLAHl7bGP45_jZn2m0NifjGQ_vQTudhdrrz7c7ON4S8d6GWWjkT8DxRgZCJCFKXh4HLNY8VF3noMKM7mcbjU_HlTJ4tkZuuFgaPVXZzYjNRm3mOe-TDKGZJhO3kkk9XvwLsGoXZ1a6FhvKtFcxOQzHmCzuO7PVvWMKVO4f7MN4fGBsdnOyNA99lIMg5F1XgXMS1jsJQWcekM7Di4QrzfdggVVpmDIR8l8LlGHeGbcepUAnLmcUvHZIxQQhYEVyksPhb-XwwnX3r8xjMF2wD0IBYkErPbQQYYthQwcSS8VsRcfUCD4Av7sa7TdwbPSGPPWClu62HrZElWzwlDyY-Jf-M6JGt6h8F3R1OO2J_EEcMW5d0tkC5qqR7t4690q91BVa3JVWFod9rmK7A4SloGdufcyxlQZ4UOms5X8t1cnovJn1Olot5YV8SCipElGwLpVUkJKALAxglgbsTNtLGDsjHznhZ7lnNsbnGZdasbmSa9XYekK1e9Kql8viX0Ho7Ar1I93yjG5DM_-Vl9tcnB2Szfw3_JyZdVGHnNcogRA45qnjRDmSvmkmOlcjy1f-VvyMPxyeT4-z4cHr0mjwCyCbaTaANslwtavsGYFGl33rfo-T8vt39D0wcHeY | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VBVVcEI9CFwoYBBKXaBM_4uaAUNWy2lK6rASV9hbs2JYQkC2bRIi_xq9jJi9UCbj1kBySyRzsycw3nhfA8xBbZU1wkSi0iaTSMspCEUehsCI1QhZxoIju2SKdn8u3K7Xagl9DLQylVQ46sVXUbl3QGfk0SblOaJycnoY-LWJ5PHt98T2iCVIUaR3GaXQicup__kD3rXp1cox7_YLz2ZuPR_OonzAQFULIOgohEdYmcWx84Co49HaEoVgfDUdVnjuH5j5keAUuguMHaSaN5gX39GWgRkyo_q9pITJKJ9Sr0dlLeF-qjRADrUCm-q5GiB6mbROYVHFxyRZe_0Kp35t_I93W4s1uwc0eqrLDTrZuw5Yv78DOWR-Mvwt25uvmc8kOp4uhpT-SE3ptKrbcEF1dsaNLCa_sfVPjevuKmdKxDw0qKhR1hlzm_tuailioQwpbdt1eq104v5IFvQfb5br0e8CQhUz0gTTWJFIhrnCITjTeg_SJdX4CL4fFy4u-nzmN1fiat36NyvJxnSfwbCS96Jp4_I1ot9uBkWR4vj9sSN7_31X-Rxon8HR8jX8mhVtM6dcN0RA4jgWxuN9t5MiaK0E1yOrB_5k_gR0U8vzdyeL0IdxArCa705992K43jX-EeKi2j1vBY_DpqiX9N22RG4A | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fetuin+A%2FNutritional+Status+Predicts+Cardiovascular+Outcomes+and+Survival+in+Hemodialysis+Patients&rft.jtitle=American+journal+of+nephrology&rft.au=Chen%2C+Hung-Yuan&rft.au=Chiu%2C+Yen-Ling&rft.au=Hsu%2C+Shih-Ping&rft.au=Pai%2C+Mei-Fen&rft.date=2014-01-01&rft.issn=0250-8095&rft.eissn=1421-9670&rft.volume=40&rft.issue=3&rft.spage=233&rft.epage=241&rft_id=info:doi/10.1159%2F000366523&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000366523 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-8095&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-8095&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-8095&client=summon |